Table 3.
The association between SUA and MetS, hypertension, central obesity, and CVD in men
| SUA levels (μmol/L) | |||||
|---|---|---|---|---|---|
| <280 | 280 ~ 320 | 320 ~ 370 | 370 ~ 420 | >420 | |
| Q1 | Q2 | Q3 | Q4 | Q5 | |
| MetS ATP | |||||
| Unadjusted | 1(reference) | 1.02 (0.88,1.19) | 1.16 (1.01,1.34) | 1.23 (1.06,1.43) | 1.71 (1.49,1.97) |
| Model 1 | 1(reference) | 1.01 (0.87,1.18) | 1.15 (1.00,1.32) | 1.22 (1.05,1.42) | 1.71 (1.49,1.97) |
| Model 2 | 1(reference) | 1.01 (0.87,1.18) | 1.15 (1.00,1.33) | 1.21 (1.04,1.40) | 1.71 (1.48,1.96) |
| Model 3a | 1(reference) | 1.03 (0.88,1.20) | 1.16 (1.01,1.34) | 1.22 (1.05,1.42) | 1.72 (1.49,1.98) |
| Model 41 | 1(reference) | 1.02 (0.87,1.20) | 1.11 (0.96,1.28) | 1.13 (0.96,1.31) | 1.51 (1.30,1.74) |
| MetS IDF | |||||
| Unadjusted | 1(reference) | 1.00 (0.86,1.16) | 1.20 (1.04,1.37) | 1.28 (1.10,1.48) | 1.68 (1.46,1.92) |
| Model 1 | 1(reference) | 0.98 (0.85,1.14) | 1.18 (1.03,1.36) | 1.26 (1.09,1.46) | 1.68 (1.46,1.93) |
| Model 2 | 1(reference) | 0.99 (0.85,1.15) | 1.19 (1.03,1.36) | 1.25 (1.08,1.45) | 1.67 (1.46,1.92) |
| Model 3a | 1(reference) | 0.99 (0.85,1.16) | 1.19 (1.04,1.37) | 1.25 (1.08,1.45) | 1.67 (1.46,1.92) |
| Model 41 | 1(reference) | 0.99 (0.84,1.17) | 1.11 (0.96,1.30) | 1.13 (0.96,1.32) | 1.40 (1.20,1.63) |
| Central obesity | |||||
| Unadjusted | 1(reference) | 1.11 (0.96,1.27) | 1.16 (1.02,1.32) | 1.32 (1.15,1.52) | 1.60 (1.40,1.82) |
| Model 1 | 1(reference) | 1.09 (0.95,1.26) | 1.15 (1.01,1.31) | 1.31 (1.13,1.50) | 1.60 (1.40,1.82) |
| Model 2 | 1(reference) | 1.09 (0.95,1.26) | 1.15 (1.01,1.31) | 1.29 (1.12,1.49) | 1.59 (1.39,1.82) |
| Model 3b | 1(reference) | 1.12 (0.97,1.30) | 1.18(1.03,1.34) | 1.32(1.14,1.52) | 1.61 (1.41,1.85) |
| Model 42 | 1(reference) | 1.12 (0.95,1.31) | 1.06(0.91,1.23) | 1.15(0.98,1.35) | 1.29 (1.11,1.51) |
| Hypertension | |||||
| Unadjusted | 1(reference) | 1.00 (0.87,1.16) | 1.26 (1.10,1.45) | 1.41 (1.22,1.64) | 1.66 (1.44,1.91) |
| Model 1 | 1(reference) | 1.03 (0.89,1.19) | 1.30 (1.13,1.49) | 1.46 (1.25,1.69) | 1.70 (1.47,1.96) |
| Model 2 | 1(reference) | 1.03 (0.89,1.20) | 1.30 (1.13,1.50) | 1.45 (1.24,1.68) | 1.70 (1.47,1.96) |
| Model 3c | 1(reference) | 1.07 (0.92,1.25) | 1.35 (1.18,1.560) | 1.52 (1.30,1.77) | 1.77 (1.53,2.06) |
| Model 43 | 1(reference) | 1.07 (0.92,1.24) | 1.29 (1.12,1.49) | 1.40 (1.20,1.64) | 1.56 (1.34,1.83) |
| CHD | |||||
| Unadjusted | 1(reference) | 1.12 (0.97,1.30) | 1.15 (1.01,1.32) | 1.24 (1.08,1.43) | 1.34 (1.17,1.53) |
| Model 1 | 1(reference) | 1.15 (1.00,1.33) | 1.17 (1.03,1.34) | 1.27 (1.10,1.46) | 1.35 (1.18,1.55) |
| Model 2 | 1(reference) | 1.14 (0.99,1.32) | 1.16 (1.02,1.33) | 1.24 (1.07,1.43) | 1.33 (1.16,1.52) |
| Model 3d | 1(reference) | 1.12 (0.97,1.30) | 1.11 (0.97,1.28) | 1.17 (1.01,1.35) | 1.24 (1.08,1.42) |
| Model 44 | 1(reference) | 1.12 (0.96,1.30) | 1.10 (0.96,1.27) | 1.18 (1.02,1.37) | 1.26 (1.09,1.45) |
| HF | |||||
| Unadjusted | 1(reference) | 0.88 (0.60,1.31) | 1.29 (0.93,1.80) | 1.15 (0.80,1.65) | 1.70 (1.24,2.34) |
| Model 1 | 1(reference) | 0.93 (0.63,1.38) | 1.34 (0.96,1.86) | 1.19 (0.83,1.72) | 1.72 (1.25,2.38) |
| Model 2 | 1(reference) | 0.95 (0.64,1.41) | 1.32 (0.94,1.85) | 1.16 (0.81,1.68) | 1.67 (1.21,2.31) |
| Model 3d | 1(reference) | 0.96 (0.65,1.43) | 1.33 (0.95,1.86) | 1.16 (0.81,1.68) | 1.65 (1.19,2.29) |
| Model 44 | 1(reference) | 0.99 (0.66,1.47) | 1.30 (0.93,1.83) | 1.17 (0.81,1.70) | 1.61 (1.15,2.24) |
| PAD | |||||
| Unadjusted | 1(reference) | 0.69 (0.38 ,1.26) | 0.59 (0.34,1.05) | 0.93 (0.54,1.59) | 0.79 (0.46,1.34) |
| Model 1 | 1(reference) | 0.72 (0.40,1.31) | 0.61 (0.34,1.07) | 0.96 (0.56,1.64) | 0.79 (0.46,1.34) |
| Model 2 | 1(reference) | 0.73 (0.40,1.33) | 0.59 (0.33,1.04) | 0.92 (0.53,1.58) | 0.74 (0.43,1.26) |
| Model 3 d | 1(reference) | 0.77 (0.42,1.40) | 0.62 (0.35,1.10) | 0.97 (0.56,1.67) | 0.76 (0.45,1.31) |
| Model 44 | 1(reference) | 0.75 (0.41,1.37) | 0.60 (0.34,1.07) | 0.93 (0.54,1.61) | 0.70 (0.40,1.22) |
Model 1: adjusted for age
Model 2: adjusted for variables included in model 1 and sedentary lifestyle, current smoke, alcohol consumption
a Model 3: adjusted for variables included in model 2 and Family history of premature CVD, CHD, cerebrovascular disease, HF, PAD; b Model 3: adjusted for variables included in model 2 and Family history of premature CVD, CHD, cerebrovascular disease, HF, PAD, T2DM, hypertension; c Model 3: adjusted for variables included in model 2 and Family history of premature CVD, CHD, cerebrovascular disease, HF, PAD, T2DM; d Model 3: adjusted for variables included in model 2 and Family history of premature CVD, T2DM, hypertension
1 Model 4: adjusted for variables included in model 3a and BMI, TC, LDL-C, Diuretic agents use; 2 Model 4: adjusted for variables included in model 3b and BMI, TC, TG, HDL-C, LDL-C, Diuretic agents use; 3 Model 4: adjusted for variables included in model 3C and BMI, TC, TG, HDL-C, LDL-C, Diuretic agents use; 4 Model 4: adjusted for variables included in model 3C and WC, TC, TG, HDL-C, LDL-C, Diuretic agents use
Abbreviations: SUA serum uric acid, MetS metabolic syndrome, CVD cardiovascular disease, ATP National Cholesterol Education Program Adult Treatment Panel III, IDF International Diabetes Federation, CHD coronary artery disease, TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, T2DM type 2 diabetes mellitus, HF heart failure, PAD peripheral artery disease